Ravi Maharjan | Pharmaceutics | Best Researcher Award

Published on by Academic Achievements

Dr. Ravi Maharjan | Pharmaceutics | Best Researcher Award

Dr. Ravi Maharjan | Pharmaceutics | Assistant Research Professor at Yonsei University | South Korea

Pharmaceutics is the foundation of Dr. Ravi Maharjan’s distinguished career as a research professor at Yonsei University, Korea, where he has been at the forefront of integrating AI/ML and Digital Twin technologies to revolutionize biopharmaceutical manufacturing, particularly in mRNA and siRNA-based lipid nanoparticle (LNP) vaccine development. Dr. Ravi Maharjan earned his PhD in Pharmaceutics and has since developed a deep expertise in biopharmaceutical process optimization, continuous manufacturing, lyophilization, stabilization strategies, and innovative delivery approaches targeting ocular and brain tissues. His professional experience spans extensive teaching, mentoring, and research leadership roles, where he has guided national and international collaborations with universities, pharmaceutical companies, and research institutions, including Pusan National University, CHA University, RCPE, RNAAnalytics Austria, and IMDEA Spain, demonstrating his ability to bridge academic research with industrial applications. Dr. Ravi Maharjan’s research interests focus on applying AI/ML algorithms for predictive modeling of complex pharmaceutical processes, optimizing formulations, ensuring protein stability, and enhancing the physical and biological stability of therapeutics. His work integrates pharmaceutics, process analytical technologies (PAT), quality by design (QbD), experimental design (DOE), and computational modeling to advance next-generation biopharmaceutical platforms. Among his key research skills are data-driven formulation design, predictive modeling, digital twin deployment, computational optimization of LNP delivery, lyophilized formulation screening, molecular simulation, process monitoring, and the translation of lab-scale research into continuous manufacturing systems. Dr. Ravi Maharjan has an impressive record of scholarly contributions, including over 23 SCIE Q1 publications, two books, two book chapters, more than 115 peer-review assignments, over 30 conference presentations, and eight invited talks. He has served as associate editor for Pharmaceutical Science and Technology (USA), editorial board member for Scientific Reports (Nature Portfolio, UK), Pharmaceutics (Switzerland), and Current Pharmaceutical Biotechnology (UAE), as well as conference organizer for multiple international events. His awards and honors recognize his contributions to both fundamental pharmaceutics and applied biopharmaceutical manufacturing, highlighting his excellence in research innovation and mentorship. Dr. Ravi Maharjan has demonstrated outstanding ability to secure funding, lead interdisciplinary projects, and foster scientific collaboration across countries and institutions, contributing to the advancement of mRNA and siRNA therapeutics, the optimization of excipients, and the improvement of drug delivery systems. His work on digital twins and AI/ML-driven process optimization has paved the way for predictive control in continuous manufacturing, ensuring reproducibility, efficiency, and quality in pharmaceutical production. In conclusion, Dr. Ravi Maharjan embodies the integration of scientific innovation, computational methods, and practical pharmaceutics expertise, making significant impacts in biopharmaceutical sciences, while continuing to mentor the next generation of researchers, drive technological innovation, and advance knowledge in AI-assisted pharmaceutical development.

Profile: Google Scholar

Featured Publications 

  1. Tripathi, J., Thapa, P., Maharjan, R., & Jeong, S. H. (2019). Current state and future perspectives on gastroretentive drug delivery systems. Citations: 246
  2. Maharjan, R., Hada, S., Lee, J. E., Han, H. K., Kim, K. H., Seo, H. J., Foged, C., … (2023). Comparative study of lipid nanoparticle-based mRNA vaccine bioprocess with machine learning and combinatorial artificial neural network-design of experiment approach. Citations: 48
  3. Maharjan, R., Kim, K. H., Lee, K., Han, H. K., & Jeong, S. H. (2024). Machine learning-driven optimization of mRNA-lipid nanoparticle vaccine quality with XGBoost/Bayesian method and ensemble model approaches. Citations: 44
  4. Maharjan, R., & Jeong, S. H. (2020). High shear seeded granulation: Its preparation mechanism, formulation, process, evaluation, and mathematical simulation. Citations: 37
  5. Bhujel, R., Maharjan, R., Kim, N. A., & Jeong, S. H. (2021). Practical quality attributes of polymeric microparticles with current understanding and future perspectives. Citations: 29
  6. Maharjan, R., Lee, J. C., Lee, K., Han, H. K., Kim, K. H., & Jeong, S. H. (2023). Recent trends and perspectives of artificial intelligence-based machine learning from discovery to manufacturing in biopharmaceutical industry. Citations: 28
  7. Kim, K. H., Lee, J. E., Lee, J. C., Maharjan, R., Oh, H., Lee, K., Kim, N. A., & Jeong, S. H. (2023). Optimization of HPLCCAD method for simultaneous analysis of different lipids in lipid nanoparticles with analytical QbD. Citations: 17

 

Shymaa Hatem | Pharmaceutics and Pharmaceutical Technology | Women Researcher Award

Published on by Academic Achievements

Assist Prof. Dr.Shymaa Hatem | Pharmaceutics and Pharmaceutical Technology | Women Researcher Award

Assistant Professor at Future University in Egypt

Dr. Shymaa Hatem Abdel-Azeem is a distinguished academic and researcher in the field of pharmaceutics and pharmaceutical technology. She currently serves as a Lecturer at the Faculty of Pharmacy, Future University in Egypt. With over a decade of academic experience, she has contributed significantly to pharmaceutical research, focusing on advanced drug delivery systems and nanotechnology-based therapies for dermatological conditions. Dr. Shymaa is recognized for her leadership in various academic and professional organizations, contributing to the advancement of pharmaceutical sciences and women’s empowerment in the Arab world.

Profile:

Google Scholar

Education:

Dr. Shymaa earned her Ph.D. in Pharmaceutical Sciences (Pharmaceutical Technology) from Ain Shams University in June 2022. Her doctoral research focused on the “Preparation and Evaluation of Topical Nanoformulations for the Treatment of Melasma.” She holds an M.Sc. in Pharmaceutical Sciences (Pharmaceutics) from Ain Shams University, completed in 2018, where her thesis examined “Preparation and Characterization of Topical Antioxidant Formulations.” In 2010, she graduated with a B.Sc. in Pharmaceutical Sciences and Pharmaceutical Industries from Cairo University, achieving an overall grade of “Excellent.”

Experience:

Dr. Shymaa has been a key academic figure at Future University in Egypt since 2012. Starting as a Teaching Assistant in the Department of Pharmaceutics and Pharmaceutical Technology, she progressed to Assistant Lecturer and eventually to her current position as Lecturer. She is also a member of the Consulting Staff at several organizations, including the International Arab-African Council for Diplomatic Relations and Peace between Nations, and the Egyptian Association of Continuing Medical Education Development. In 2023, she was certified as an expert in Arabic women’s issues by the International Leadership Center.

Research Interest:

Dr. Shymaa’s research interests are centered around the development of innovative drug delivery systems, with a special focus on nanotechnology. Her work emphasizes the formulation of topical treatments for dermatological conditions such as melasma, psoriasis, and acne. She also explores the application of nanostructured lipid carriers and vesicular systems for the enhanced delivery of active pharmaceutical ingredients to the skin and brain. Her goal is to enhance the clinical efficacy of drugs using novel pharmaceutical technologies.

Awards:

Throughout her career, Dr. Shymaa has earned recognition for her contributions to the field of pharmaceutical sciences. In 2024, she completed the Training of Trainers (TOT) program from Ain Shams University, which certified her as a professional trainer. Her leadership and active participation in community services, particularly in women’s empowerment, have also been acknowledged by various professional organizations.

Publications:

Dr. Shymaa has published extensively in high-impact journals, with her research widely cited within the scientific community. Below are selected publications, complete with links and journal details:

“Clinical Cosmeceutical Repurposing of Melatonin in Androgenic Alopecia Using Nanostructured Lipid Carriers Prepared with Antioxidant Oils” (2018). Published in Expert Opinion on Drug Delivery and cited by 62 articles. Link to paper.

“Melatonin Vitamin C-based Nanovesicles for Treatment of Androgenic Alopecia: Design, Characterization, and Clinical Appraisal” (2018). Published in European Journal of Pharmaceutical Sciences and cited by 48 articles. Link to paper.

“Recent Advances in Antioxidant Cosmeceutical Topical Delivery” (2018). Published in Current Drug Delivery and cited by 36 articles. Link to paper.

“Background and Different Treatment Modalities for Melasma: Conventional and Nanotechnology-Based Approaches” (2020). Published in Journal of Drug Delivery Science and Technology and cited by 25 articles. Link to paper.

“Functionalized Chitosan Nanoparticles for Cutaneous Delivery of a Skin Whitening Agent: An Approach to Clinically Augment the Therapeutic Efficacy for Melasma Treatment” (2022). Published in Drug Delivery and cited by 14 articles. Link to paper.

“Optimization of the Colloidal Properties of Chitosan Nanoparticles Encapsulating Alpha-Arbutin” (2022). Published in Archives of Pharmaceutical Sciences Ain Shams University and cited by 8 articles. Link to paper.

“Novel Anti-Psoriatic Nanostructured Lipid Carriers for the Cutaneous Delivery of Luteolin: A Comprehensive In-Vitro and In-Vivo Evaluation” (2023). Published in European Journal of Pharmaceutical Sciences and cited by 5 articles. Link to paper.

Conclusion:

Shymaa Hatem Abdel-Azeem is a highly competent researcher with notable achievements in pharmaceutical nanotechnology and drug delivery systems. Her leadership roles and academic contributions, especially to women’s issues in the Arab world, underscore her qualifications for the “Research for Women Researcher Award.” By continuing to grow her international collaborations, expanding her research focus, and securing further funding, she can further solidify her standing as an influential figure in her field.